ACRS logo

Aclaris Therapeutics (ACRS) Company Overview

Profile

Full Name:

Aclaris Therapeutics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

October 6, 2015

Indexes:

Not included

Description:

Aclaris Therapeutics is a biotechnology company focused on developing innovative treatments for skin diseases and conditions. They specialize in dermatology, particularly in therapies for alopecia, psoriasis, and other skin disorders, using advanced technology to create effective solutions for patients.

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 23, 24 HC Wainwright & Co.
Buy
Nov 19, 24 Leerink Partners
Outperform
Nov 19, 24 Jefferies
Buy
Nov 19, 24 BTIG
Buy
Nov 18, 24 Piper Sandler
Overweight
Sep 17, 24 HC Wainwright & Co.
Neutral
Aug 19, 24 HC Wainwright & Co.
Neutral
Jul 22, 24 HC Wainwright & Co.
Neutral
Jan 22, 24 HC Wainwright & Co.
Neutral
Jan 11, 24 BTIG
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Aclaris Therapeutics?
  • Does Aclaris Therapeutics pay dividends?
  • What sector is Aclaris Therapeutics in?
  • What industry is Aclaris Therapeutics in?
  • What country is Aclaris Therapeutics based in?
  • When did Aclaris Therapeutics go public?
  • Is Aclaris Therapeutics in the S&P 500?
  • Is Aclaris Therapeutics in the NASDAQ 100?
  • Is Aclaris Therapeutics in the Dow Jones?
  • When was Aclaris Therapeutics's last earnings report?
  • When does Aclaris Therapeutics report earnings?
  • Should I buy Aclaris Therapeutics stock now?

What is the ticker symbol for Aclaris Therapeutics?

The ticker symbol for Aclaris Therapeutics is NASDAQ:ACRS

Does Aclaris Therapeutics pay dividends?

No, Aclaris Therapeutics does not pay dividends

What sector is Aclaris Therapeutics in?

Aclaris Therapeutics is in the Healthcare sector

What industry is Aclaris Therapeutics in?

Aclaris Therapeutics is in the Diagnostics & Research industry

What country is Aclaris Therapeutics based in?

Aclaris Therapeutics is headquartered in United States

When did Aclaris Therapeutics go public?

Aclaris Therapeutics's initial public offering (IPO) was on October 6, 2015

Is Aclaris Therapeutics in the S&P 500?

No, Aclaris Therapeutics is not included in the S&P 500 index

Is Aclaris Therapeutics in the NASDAQ 100?

No, Aclaris Therapeutics is not included in the NASDAQ 100 index

Is Aclaris Therapeutics in the Dow Jones?

No, Aclaris Therapeutics is not included in the Dow Jones index

When was Aclaris Therapeutics's last earnings report?

Aclaris Therapeutics's most recent earnings report was on Nov 6, 2024

When does Aclaris Therapeutics report earnings?

The next expected earnings date for Aclaris Therapeutics is May 7, 2025

Should I buy Aclaris Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions